Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
127 studies found for:    Cystitis, Interstitial
Show Display Options
Rank Status Study
21 Withdrawn Effect of Intravesical Lidocaine on Urodynamic and Symptomatic Parameters of Interstitial Cystitis
Condition: Interstitial Cystitis
Interventions: Procedure: Urodynamic study;   Drug: Lidocaine;   Other: Normal Saline
22 Completed
Has Results
Efficacy Study of Adalimumab to Treat Interstitial Cystitis
Condition: Interstitial Cystitis
Interventions: Drug: Adalimumab;   Other: inactive drug
23 Recruiting Osteopathic Manipulation for Female Interstitial Cystitis Patients With Sacroiliac Joint Dysfunction
Conditions: Interstitial Cystitis;   Sacroiliac Joint Somatic Dysfunction
Intervention: Procedure: Osteopathic Manipulation Therapy
24 Recruiting Clinical Efficacy of Changing the InterStim® Parameters in Patients With Interstitial Cystitis/Painful Bladder Syndrome
Conditions: Painful Bladder Syndrome;   Interstitial Cystitis;   Pelvic Floor; Insufficiency;   Bowel Dysfunction;   Sexual Dysfunction;   Pelvic Floor; Incompetency
Intervention: Other: Changing the Interstim parameter of '' Frequency" in patients with Interstitial Cystitis
25 Active, not recruiting Prospective Trial Comparing Response to Hyperbaric Oxygen Treatment in Patients With Interstitial Cystitis
Condition: Interstitial Cystitis
Intervention: Procedure: HBOT
26 Terminated
Has Results
Effectiveness and Safety Study of Pentosan Polysulfate Sodium for the Treatment of Interstitial Cystitis
Condition: Interstitial Cystitis
Interventions: Drug: Pentosan polysulfate sodium 100 mg;   Drug: Placebo
27 Completed
Has Results
Phase II Study Efficacy and Safety of Two Dosing Regimens of MN-001 in Patients With Interstitial Cystitis
Condition: Interstitial Cystitis
Interventions: Drug: MN-001 BID;   Drug: MN-001;   Drug: Placebo
28 Recruiting Evaluation of Intravesical LP08 in Patients With Interstitial Cystitis/Painful Bladder Syndrome
Condition: Interstitial Cystitis
Interventions: Drug: LP-08 80mg;   Drug: Normal Saline Placebo;   Drug: LP-08 20mg
29 Unknown  Comparative Study Between Hyperbaric Therapy and Intravesical Dimethyl Sulfoxide Instillation for Interstitial Cystitis
Condition: Interstitial Cystitis
Interventions: Other: Hyperbaric Oxygen Therapy;   Drug: DMSO
30 Unknown  Intravesical Botulinum Toxin A Injections in Treatment of Interstitial Cystitis Refractory to Conventional Treatment
Condition: Interstitial Cystitis
Interventions: Drug: Botulinum toxin A;   Drug: Normal saline instillation
31 Terminated A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder Pain
Conditions: Cystitis, Interstitial;   Urologic Diseases;   Urinary Bladder Diseases;   Cystitis
Interventions: Drug: Placebo;   Drug: JNJ-42160443
32 Completed A Pilot Clinical Investigation of the Efficacy and Safety of Uracyst® Versus Placebo in Patients With Interstitial Cystitis/Painful Bladder Syndrome.
Condition: Interstitial Cystitis
Interventions: Device: placebo;   Device: Uracyst
33 Terminated Trial Comparing Intravesical Cocktail With Intravesical Dimethyl Sulfoxide (DMSO) in Painful Bladder Syndrome/Interstitial Cystitis (PBS/IC)
Conditions: Interstitial Cystitis;   Bladder Diseases
Interventions: Drug: dimethyl sulfoxide;   Drug: IC Cocktail
34 Recruiting Interstitial Cystitis (IC)-Like Findings With Hydrodistension
Condition: Interstitial Cystitis
Interventions: Procedure: Hydrodistension;   Device: Cystoscopy
35 Unknown  Genetic Studies in Interstitial Cystitis
Conditions: Interstitial Cystitis;   Painful Bladder Syndrome;   Chronic Pelvic Pain Syndrome
Intervention:
36 Completed Cyclosporine in Interstitial Cystitis: Efficacy, Safety and Mechanism of Action
Condition: Interstitial Cystitis
Intervention: Drug: Cyclosporine
37 Completed Relationship of Interstitial Cystitis to Vulvodynia
Condition: Interstitial Cystitis
Intervention: Other: Physical Examination
38 Active, not recruiting A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome
Conditions: Cystitis, Interstitial;   Painful Bladder Syndrome
Interventions: Device: LiRIS®;   Device: LiRIS Placebo
39 Recruiting A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis With Hunner's Lesions
Conditions: Cystitis, Interstitial;   Ulcer
Interventions: Drug: LiRIS®;   Drug: LiRIS Placebo
40 Terminated Safety and Efficacy of AGN 203818 for Pain Associated With Painful Bladder Syndrome/Interstitial Cystitis
Condition: Cystitis, Interstitial
Intervention: Drug: AGN 203818

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years